Mabpharm Ltd. files director list with HKEX
Mabpharm Ltd. has filed an updated list of directors with the Hong Kong Stock Exchange. The Board comprises Executive Directors Dr. Wang Hao (Chief Executive Officer), Mr. Li Yunfeng, Mr. Tao Jing, Dr. Hou Sheng, and Dr. Qian Weizhu. Non-executive Directors include Mr. Jiao Shuge (Chairman) and Mr. Cen Jialin. The Independent Non-executive Directors are Dr. Zhang Yanyun (Lead Independent Non-executive Director), Mr. Guo Liangzhong, Mr. Leung, Louis Ho Ming, and Dr. Tao Qian. The company has established three committees. The Audit Committee is chaired by Mr. Leung, Louis Ho Ming, with members Mr. Jiao Shuge and Mr. Guo Liangzhong. The Remuneration Committee is chaired by Dr. Zhang Yanyun, with Dr. Wang Hao and Mr. Guo Liangzhong as members. The Nomination Committee is chaired by Mr. Guo Liangzhong, with Dr. Qian Weizhu and Dr. Zhang Yanyun serving as members.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabpharm Ltd. published the original content used to generate this news brief on October 31, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.